Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer.

Saya Jacob, MacKenzie Johnson, Brianna Roque,Laura Quintal,Hope S Rugo,Michelle Melisko,Amy Jo Chien

Clinical breast cancer（2023）

引用 0|浏览2

暂无评分

摘要

This is the first study to investigate crofelemer for neratinib-induced diarrhea and demonstrates crofelemer activity in this setting. Further investigation of crofelemer for diarrhea secondary to cancer treatment is needed.

查看译文

关键词

breast cancer,crofelemer,neratinib-associated,early-stage

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要